{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:45:41Z","timestamp":1786549541609,"version":"build-2736575974"},"reference-count":181,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Vitamin A plays an important role in multiple homeostatic functions such as vision, immunity, epithelial cell integrity and differentiation, cell signaling, pulmonary function, reproduction, growth, and development. Vitamin A deficiency was described in people with cystic fibrosis (pwCF) due to a multitude of causes, such as suboptimally managed exocrine pancreatic insufficiency, advanced cystic fibrosis-related liver disease (aCFLD), and a history of intestinal resection, and is generally rare in contemporary practice. Apart from true vitamin A deficiency, low vitamin A levels may also be noted in various inflammatory states, as vitamin A is a negative acute-phase reactant. In the current era of cystic fibrosis (CF) transmembrane-conductance regulator (CFTR)-directed therapies, there is a paradigm shift in vitamin A status, with deficiency statuses becoming rarer, and instead higher serum vitamin levels (in some cases, even in the hypervitaminosis range) are increasingly reported. People with aCFLD, renal insufficiency, post-lung transplantation, and pregnancy are prone to vitamin A toxicity. Hence, CF clinicians should be proactive in evaluating these abnormalities and proficient in managing both deficiency and toxicity, as both these conditions can be associated with adverse outcomes. In this review, we detailed the basics of vitamin A metabolism, manifestations of both vitamin A deficiency and excess, and their clinical implications in pwCF.<\/jats:p>","DOI":"10.3390\/nu18162639","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:45:06Z","timestamp":1786545906000},"page":"2639","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vitamin A Status in Cystic Fibrosis in the Current Era of CFTR-Directed Therapies"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3094-9703","authenticated-orcid":false,"given":"Senthilkumar","family":"Sankararaman","sequence":"first","affiliation":[{"name":"Division of Pediatric Gastroenterology, Cleveland Clinic Children\u2019s Hospital, Cleveland, OH 44195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3001-4588","authenticated-orcid":false,"given":"Terri","family":"Schindler","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology, UH Rainbow Babies & Children\u2019s Hospital, Cleveland, OH 44106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Vavrina","sequence":"additional","affiliation":[{"name":"Gastroenterology Care, AbbVie, 7575 Frankford Road #3213, Dallas, TX 75252, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mascarenhas","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Children\u2019s Hospital of Philadelphia, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"ref_1","unstructured":"CFF (2026, June 24). Cystic Fibrosis Foundation. Available online: https:\/\/www.cff.org\/managing-cf\/vitamins."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/neu.20242","article-title":"Overview of retinoid metabolism and function","volume":"66","author":"Blomhoff","year":"2006","journal-title":"J. Neurobiol."},{"key":"ref_3","first-page":"CD006751","article-title":"Vitamin A and beta (\u03b2)-carotene supplementation for cystic fibrosis","volume":"8","author":"Chang","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clnu.2023.12.017","article-title":"ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis","volume":"43","author":"Wilschanski","year":"2024","journal-title":"Clin. Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpedi.1938.01980140114013","article-title":"CF of the pancreas and its relation to celiac disease: A clinical and pathologic study","volume":"56","author":"Andersen","year":"1938","journal-title":"Am. J. Dis. Child."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/adc.64.8.1151","article-title":"Night blindness and conjunctival xerosis caused by vitamin A deficiency in patients with cystic fibrosis","volume":"64","author":"Rayner","year":"1989","journal-title":"Arch. Dis. Child."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/j.1536-4801.1990.tb09983.x","article-title":"Vitamin A in cystic fibrosis: Case report and review of the literature","volume":"10","author":"Eid","year":"1990","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bjo.83.6.688","article-title":"Ocular signs and symptoms and vitamin A status in patients with cystic fibrosis treated with daily vitamin A supplements","volume":"83","author":"Ansari","year":"1999","journal-title":"Br. J. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s004310050749","article-title":"Vitamin A deficiency and nocturnal vision in teenagers with cystic fibrosis","volume":"156","author":"Huet","year":"1997","journal-title":"Eur. J. Pediatr."},{"key":"ref_10","first-page":"662","article-title":"Vitamin A deficiency with xerophthalmia and night blindness in cystic fibrosis","volume":"116","author":"Petersen","year":"1968","journal-title":"Am. J. Dis. Child."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/bjo.71.10.787","article-title":"Vitamin A deficiency in treated cystic fibrosis: Case report","volume":"71","author":"Talbot","year":"1987","journal-title":"Br. J. Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/eye.1989.52","article-title":"Nyctalopia and conjunctival xerosis indicating vitamin A deficiency in cystic fibrosis","volume":"3","author":"Neugebauer","year":"1989","journal-title":"Eye"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/adc.56.9.708","article-title":"Vitamin status in treated patients with cystic fibrosis","volume":"56","author":"Congden","year":"1981","journal-title":"Arch. Dis. Child."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ajcn\/20.5.415","article-title":"Vitamin A, vitamin E, and lipids in serum of children with cystic fibrosis or congenital heart defects compared with normal children","volume":"20","author":"Bennett","year":"1967","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archopht.1990.01070050052029","article-title":"Xerophthalmia and cystic fibrosis","volume":"108","author":"Brooks","year":"1990","journal-title":"Arch. Ophthalmol."},{"key":"ref_16","first-page":"345","article-title":"Vitamin A status and its determinants in patients with cystic fibrosis","volume":"16","author":"Sapiejka","year":"2017","journal-title":"Acta Sci. Pol. Technol. Aliment."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MPG.0000000000000683","article-title":"Intestinal inflammation and impact on growth in children with cystic fibrosis","volume":"60","author":"Dhaliwal","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/jclinpath-2013-201787","article-title":"Fat-soluble vitamin deficiency in children and adolescents with cystic fibrosis","volume":"67","author":"Rana","year":"2014","journal-title":"J. Clin. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Norsa, L., Zazzeron, L., Cuomo, M., Claut, L., Bulfamante, A.M.C., Biffi, A., and Colombo, C. (2019). Night blindness in cystic fibrosis: The key role of vitamin A in the digestive system. Nutrients, 11.","DOI":"10.3390\/nu11081876"},{"key":"ref_20","unstructured":"Bell, S.C. (2017). The Australian and New Zealand Cystic Fibrosis Nutrition Guideline Authorship Group. Nutrition Guidelines for Cystic Fibrosis in Australia and New Zealand, Thoracic Society of Australia and New Zealand. Available online: https:\/\/thoracic.org.au\/wp-content\/uploads\/2021\/06\/NHMRC-NutritionGuidelines-CF-ANZ-final-web.pdf."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.paed.2020.07.002","article-title":"Gastrointestinal complications of cystic fibrosis","volume":"30","author":"Ng","year":"2020","journal-title":"Paediatr. Child Health"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MPG.0b013e31804069e5","article-title":"Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis","volume":"45","author":"Hakim","year":"2007","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/j.jcf.2025.03.1209","article-title":"P324 Vitamin A deficiency and Mycobacterium abscessus","volume":"24","author":"Moore","year":"2025","journal-title":"J. Cyst. Fibros."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/S1569-1993(24)00658-1","article-title":"P362 Vitamin A deficiency in the West of Scotland Adult CF Centre","volume":"23","author":"Moore","year":"2024","journal-title":"J. Cyst. Fibros."},{"key":"ref_25","first-page":"CD006751","article-title":"Vitamin A supplementation for cystic fibrosis","volume":"14","author":"Bonifant","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1590\/s1806-37562017000000065","article-title":"Brazilian guidelines for the diagnosis and treatment of cystic fibrosis","volume":"43","author":"Athanazio","year":"2017","journal-title":"J. Bras. Pneumol."},{"key":"ref_27","unstructured":"(2026, June 24). Canadian (British Columbia) Cystic Fibrosis Care Guidelines for Nutrition Management, Available online: https:\/\/www2.gov.bc.ca\/assets\/gov\/health\/practitioner-pro\/bc-guidelines\/cystic-fibrosis\/cf_care_guidelines_for_nutrition_management.pdf."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/MPG.0000000000001349","article-title":"Highlights of the ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants and children with cystic fibrosis","volume":"63","author":"Wilschanski","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","article-title":"ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis","volume":"35","author":"Turck","year":"2016","journal-title":"Clin. Nutr."},{"key":"ref_30","first-page":"246","article-title":"Consensus report on nutrition for pediatric patients with cystic fibrosis","volume":"35","author":"Borowitz","year":"2002","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.jcjo.2021.04.018","article-title":"Papilledema and hypervitaminosis A after elexacaftor\/tezacaftor\/ivacaftor for cystic fibrosis","volume":"57","author":"Miller","year":"2022","journal-title":"Can. J. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1164\/rccm.202303-0380LE","article-title":"Raised intracranial pressure in three children with cystic fibrosis receiving elexacaftor-tezacaftor-ivacaftor modulator therapy","volume":"208","author":"Southern","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2268S","DOI":"10.3945\/jn.109.119024","article-title":"\u03b2-Carotene is an important vitamin A source for humans","volume":"140","author":"Grune","year":"2010","journal-title":"J. Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3945\/an.116.014720","article-title":"Vitamin A","volume":"8","author":"Debelo","year":"2017","journal-title":"Adv. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1816S","DOI":"10.3945\/jn.115.229708","article-title":"Biomarkers of Nutrition for Development (BOND)\u2014Vitamin A review","volume":"146","author":"Tanumihardjo","year":"2016","journal-title":"J. Nutr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1167\/iovs.66.12.30","article-title":"Selective Impairment of Rod-Driven Vision in Vitamin A Deficiency: Insights From Examining the Effect of Desensitizing Backgrounds","volume":"66","author":"Margetts","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3067126","DOI":"10.1155\/2018\/3067126","article-title":"Impact of retinoic acid on immune cells and inflammatory diseases","volume":"2018","author":"Oliveira","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-8223(01)00078-5","article-title":"Dietary reference intakes: Vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc","volume":"101","author":"Trumbo","year":"2001","journal-title":"J. Am. Diet. Assoc."},{"key":"ref_39","unstructured":"(2026, June 24). Dermnentz. Available online: https:\/\/dermnetnz.org\/topics\/oral-retinoids."},{"key":"ref_40","unstructured":"Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Subcommittee of Interpretation Uses of Dietary Reference Intakes Subcommittee on Upper Reference Levels of Nutrients Panel on Micronutrients (2026, June 24). Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK222310."},{"key":"ref_41","unstructured":"(2026, May 03). Vitamin A. Linus Pauling Institute Micronutrient Information Center. Available online: https:\/\/lpi.oregonstate.edu\/mic\/vitamins\/vitamin-A."},{"key":"ref_42","unstructured":"Cawood, A.L. (2003). Vitamin A Metabolism, in Healthy Adults and Patients with Cystic Fibrosis. [Ph.D. Thesis, University of Southampton]."},{"key":"ref_43","first-page":"34","article-title":"Correlations between plasma and liver concentrations of vitamins A and E in children with cystic fibrosis","volume":"47","author":"Underwood","year":"1971","journal-title":"Bull. N. Y. Acad. Med."},{"key":"ref_44","first-page":"14","article-title":"The role of vitamins in cystic fibrosis","volume":"93","author":"Carr","year":"2000","journal-title":"J. R. Soc. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(95)91157-X","article-title":"Vitamin A","volume":"345","author":"Bates","year":"1995","journal-title":"Lancet"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Munck, A., Enaud, R., Languepin, J., Remus, N., Wizla, N., Chedevergne, F., Bui, S., Arrouy, A., Mittaine, M., and Quinn, M. (2025). Impact of a Cystic Fibrosis Specific Multivitamin Formulation on Fat-Soluble Vitamin Status and Treatment Satisfaction in Young Children. Children, 12.","DOI":"10.3390\/children12091149"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1096\/fasebj.10.5.8621054","article-title":"Absorption, metabolism, and transport of carotenoids","volume":"10","author":"Parker","year":"1996","journal-title":"FASEB J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/cts.12402","article-title":"Chronic kidney disease alters vitamin A homeostasis via effects on hepatic RBP4 protein expression and metabolic enzymes","volume":"9","author":"Jing","year":"2016","journal-title":"Clin. Transl. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1053\/j.gastro.2025.03.010","article-title":"Regulation of Hepatic Stellate Cell Phenotypes in Metabolic Dysfunction-Associated Steatohepatitis","volume":"169","author":"Kisseleva","year":"2025","journal-title":"Gastroenterology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J. Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12565-017-0395-9","article-title":"The stellate cell system (vitamin A-storing cell system)","volume":"92","author":"Senoo","year":"2017","journal-title":"Anat. Sci. Int."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Steinhoff, J.S., Lass, A., and Schupp, M. (2021). Biological functions of RBP4 and its relevance for human diseases. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.659977"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/ajcn\/73.3.594","article-title":"Retinol binding protein as a surrogate measure for serum retinol: Studies in vitamin A\u2013deficient children from the Republic of the Marshall Islands","volume":"73","author":"Gamble","year":"2001","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Sanguinetti, C., Minniti, M., Susini, V., Caponi, L., Panichella, G., Castiglione, V., Aimo, A., Emdin, M., Vergaro, G., and Franzini, M. (2022). The journey of human transthyretin: Synthesis, structure stability, and catabolism. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081906"},{"key":"ref_55","unstructured":"Newcomer, M.E., and Ong, D.E. (2013). Retinol binding protein and its interaction with transthyretin. Madame Curie Bioscience Database, Landes Bioscience."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0083-6729(06)75006-3","article-title":"Vitamin A-storing cells (stellate cells)","volume":"75","author":"Senoo","year":"2007","journal-title":"Vitam. Horm."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"435S","DOI":"10.1093\/ajcn\/68.2.435S","article-title":"Interactions between zinc and vitamin A: An update","volume":"68","author":"Christian","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ajcn\/56.4.735","article-title":"McCollum Award Lecture, 1992: Vitamin A absorption, transport, cellular uptake, and storage","volume":"56","author":"Norum","year":"1992","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_59","first-page":"240","article-title":"Hypervitaminosis-A in Chronic Kidney Disease: Accumulation of Retinoids and Retinol-Binding Protein","volume":"12","author":"Varnell","year":"2023","journal-title":"Vitam. Min."},{"key":"ref_60","unstructured":"Tanumihardjo, S. (2026, June 01). Principles of Nutritional Assessment: Vitamin A. Available online: https:\/\/nutritionalassessment.org\/vitamina."},{"key":"ref_61","first-page":"264","article-title":"Vitamin A concentration in the liver decreases with age in patients with cystic fibrosis","volume":"24","author":"Lindblad","year":"1997","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"290S","DOI":"10.1093\/jn\/134.1.290S","article-title":"Assessing vitamin A status: Past, present and future","volume":"134","author":"Tanumihardjo","year":"2004","journal-title":"J. Nutr."},{"key":"ref_63","unstructured":"WHO (2026, June 01). Available online: https:\/\/www.who.int\/data\/nutrition\/nlis\/info\/vitamin-a-deficiency."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/tropej\/44.2.96","article-title":"Age and sex are important factors in determining normal retinol levels","volume":"44","author":"Lindblad","year":"1998","journal-title":"J. Trop. Pediatr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/ajcn\/72.5.1170","article-title":"Serum retinol, the acute phase response, and the apparent misclassification of vitamin A status in the third National Health and Nutrition Examination Survey","volume":"72","author":"Stephensen","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_66","unstructured":"(2026, June 24). Mayo Clinic. Available online: https:\/\/www.mayocliniclabs.com\/test-catalog\/overview\/605267."},{"key":"ref_67","unstructured":"(2026, June 24). ARUPLAB. Available online: https:\/\/ltd.aruplab.com\/Tests\/Pub\/0080525."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Degrassi, I., Leonardi, I., Di Profio, E., Montanari, C., Zuccotti, G., and Verduci, E. (2023). Fat-Soluble vitamins deficiency in pediatric cholestasis: A scoping review. Nutrients, 15.","DOI":"10.3390\/nu15112491"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/hep.20864","article-title":"Comparison of indices of vitamin A status in children with chronic liver disease","volume":"42","author":"Feranchak","year":"2005","journal-title":"Hepatology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1177\/0884533611420442","article-title":"Night blindness in a teenager with cystic fibrosis","volume":"26","author":"Roddy","year":"2011","journal-title":"Nutr. Clin. Pract."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jcf.2004.04.003","article-title":"Vitamin A levels in patients with CF are influenced by the inflammatory response","volume":"3","author":"Greer","year":"2004","journal-title":"J. Cyst. Fibros."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/ajcn\/64.4.635","article-title":"Vitamin A status in acute exacerbations of cystic fibrosis","volume":"64","author":"Duggan","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(03)15099-4","article-title":"Effects of subclinical infection on plasma retinol concentrations and assessment of prevalence of vitamin A deficiency: Meta-analysis","volume":"362","author":"Thurnham","year":"2003","journal-title":"Lancet"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.clnu.2015.04.010","article-title":"Vitamin A intake and serum retinol levels in children and adolescents with cystic fibrosis","volume":"35","author":"Woestenenk","year":"2016","journal-title":"Clin. Nutr."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MCP.0b013e3283136787","article-title":"Update on fat-soluble vitamins in cystic fibrosis","volume":"14","author":"Maqbool","year":"2008","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00431-004-1587-6","article-title":"Retinol binding protein status in relation to ocular surface changes in patients with cystic fibrosis treated with daily vitamin A supplements","volume":"164","author":"Mrugacz","year":"2005","journal-title":"Eur. J. Pediatr."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/gut.33.5.707","article-title":"Vitamin A absorption in cystic fibrosis: Risk of hypervitaminosis A","volume":"33","author":"James","year":"1992","journal-title":"Gut"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.clnu.2013.01.009","article-title":"Individualized vitamin A supplementation for patients with cystic fibrosis","volume":"32","author":"Brei","year":"2013","journal-title":"Clin. Nutr."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/ajcn\/33.9.2031","article-title":"The interaction of vitamin A and zinc: Implications for human nutrition","volume":"33","author":"Solomons","year":"1980","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jcf.2007.11.005","article-title":"Zinc therapy for night blindness in cystic fibrosis","volume":"7","author":"Tinley","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/ajcn\/32.6.1253","article-title":"The effect of oral zinc supplementation on plasma levels of vitamin A and retinol-binding protein in cystic fibrosis","volume":"32","author":"Palin","year":"1979","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/jpc.13243","article-title":"Vitamin A deficiency and xerophthalmia in children of a developed country","volume":"52","author":"Chiu","year":"2016","journal-title":"J. Paediatr. Child Health"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/13816819209046488","article-title":"Electro-oculogram in vitamin A deficiency associated with cystic fibrosis. Short communication","volume":"13","author":"Leguire","year":"1992","journal-title":"Ophthalmic Paediatr. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1752-1947-2-201","article-title":"An atypical presentation of cystic fibrosis: A case report","volume":"2","author":"Joshi","year":"2008","journal-title":"J. Med. Case Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-277X.1998.00129.x","article-title":"Vitamin A deficiency in cystic fibrosis resulting in xerophthalmia","volume":"11","author":"Campbell","year":"1998","journal-title":"J. Hum. Nutr. Diet."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00004397-200010000-00007","article-title":"Vitamin A deficiency and the eye","volume":"40","author":"Smith","year":"2000","journal-title":"Int. Ophthalmol. Clin."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/BF00164674","article-title":"Ocular findings in cystic fibrosis patients receiving vitamin A supplementation","volume":"233","author":"Morkeberg","year":"1995","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1513\/AnnalsATS.201404-170BC","article-title":"Hypervitaminosis A causing hypercalcemia in cystic fibrosis. Case report and focused review","volume":"11","author":"Safi","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.64483\/202522588","article-title":"Clinical and Nutritional Implications of Vitamin A-An Updated Review for Dietitian and Nutritionists","volume":"2","author":"Sahari","year":"2025","journal-title":"Saudi J. Med. Public. Health"},{"key":"ref_90","first-page":"2237","article-title":"Potential Dietary Supplement-drug Interactions: Fat-soluble Vitamins","volume":"42","author":"Mahmood","year":"2023","journal-title":"Lat. Am. J. Pharm."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/ncp.10899","article-title":"Update on the management of vitamins and minerals in cystic fibrosis","volume":"37","author":"Sankararaman","year":"2022","journal-title":"Nutr. Clin. Pract."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/S1569-1993(24)00664-7","article-title":"P368 Alterations in fat soluble vitamin levels in adults with cystic fibrosis","volume":"23","author":"Ochota","year":"2024","journal-title":"J. Cyst. Fibros."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"398","DOI":"10.36311\/jhgd.v36.18788","article-title":"Brazilian guidelines for nutrition in cystic fibrosis\u20132026","volume":"36","author":"Guirau","year":"2026","journal-title":"J. Hum. Growth Dev."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/lt.23646","article-title":"High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation","volume":"19","author":"Venu","year":"2013","journal-title":"Liver Transplant."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/HEP.0000000000000646","article-title":"Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations","volume":"79","author":"Sellers","year":"2024","journal-title":"Hepatology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1753495X14554022","article-title":"Pregnancy and cystic fibrosis: Approach to contemporary management","volume":"7","author":"Geake","year":"2014","journal-title":"Obstet. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/S1569-1993(24)00659-3","article-title":"P363 A retrospective review of fat-soluble vitamins A, D and E levels and vitamin supplementation in a cystic fibrosis (CF) maternal health population","volume":"23","author":"Brockie","year":"2024","journal-title":"J. Cyst. Fibros."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000531131","article-title":"A case of autism spectrum disorder with perforated keratomalacia due to vitamin A deficiency","volume":"14","author":"Nakata","year":"2023","journal-title":"Case Rep. Ophthalmol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"198.e1","DOI":"10.1016\/j.jaapos.2023.05.009","article-title":"Potential blindness from nutritional xerophthalmia in autistic patients","volume":"27","author":"Marek","year":"2023","journal-title":"J. Am. Assoc. Pediatr. Ophthalmol. Strabismus"},{"key":"ref_100","first-page":"CD008524","article-title":"Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age","volume":"3","author":"Imdad","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e0015","DOI":"10.1097\/coa.0000000000000015","article-title":"Deficiency in the Midst of Abundance: Xerophthalmia Case Series and Vitamin A Levels in a New England Hospital","volume":"2","author":"Li","year":"2023","journal-title":"Cornea Open"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e70896","DOI":"10.1002\/ccr3.70896","article-title":"Xerophthalmia and Nyctalopia as Presenting Signs of Vitamin A Deficiency in a Patient With Rapid Intentional Weight Loss: A Case Report and Literature Review","volume":"13","author":"Shoeibi","year":"2025","journal-title":"Clin. Case Rep."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Francalanci, M., Terlizzi, V., Fevola, C., Di Rosa, G., Pierattini, V., Roselli, E., Bonomi, P., Cavicchi, M.C., Galici, V., and Neri, A.S. (2023). Nutritional status and circulating levels of fat-soluble vitamins in cystic fibrosis patients: A cohort study and evaluation of the effect of CFTR modulators. Children, 10.","DOI":"10.3390\/children10020252"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Hevilla, F., Porras, N., Gir\u00f3n, M.V., Garc\u00eda-Olivares, M., Padial, M., S\u00e1nchez-Torralvo, F.J., Olveira, C., and Olveira, G. (2024). Impact of elexacaftor\u2013tezacaftor\u2013ivacaftor therapy on body composition, dietary intake, biomarkers, and quality of life in people with cystic fibrosis: A prospective observational study. Nutrients, 16.","DOI":"10.3390\/nu16193293"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jcf.2023.08.002","article-title":"The impact of elexacaftor\/tezacaftor\/ivacaftor on fat-soluble vitamin levels in people with cystic fibrosis","volume":"22","author":"Hergenroeder","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.paed.2026.01.003","article-title":"Effects of CFTR modulators throughout life with cystic fibrosis","volume":"36","author":"Brand","year":"2026","journal-title":"Paediatr. Child Health"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jcf.2023.04.019","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on fat-soluble vitamin levels in children with cystic fibrosis","volume":"22","author":"Schembri","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/ppul.26823","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on lipid and fat-soluble vitamin levels and association with body mass index","volume":"59","author":"Patel","year":"2024","journal-title":"Pediatr. Pulmonol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jcf.2026.02.004","article-title":"Consensus-based guidance for the nutritional management of children with cystic fibrosis on ELEXACAFTOR\/TEZACAFTOR\/IVACAFTOR","volume":"25","author":"Katz","year":"2026","journal-title":"J. Cyst. Fibros."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00431-026-06742-8","article-title":"Role of elexacaftor-tezacaftor-ivacaftor therapy on fecal elastase-1 and fat-soluble vitamins in children with cystic fibrosis","volume":"185","author":"Akyan","year":"2026","journal-title":"Eur. J. Pediatr."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40348-024-00178-6","article-title":"Changes in vitamins and trace elements after initiation of highly effective CFTR modulator therapy in children and adults with cystic fibrosis\u2013a real-life insight","volume":"11","author":"Fabricius","year":"2024","journal-title":"Mol. Cell. Pediatr."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Carnovale, V., Scial\u00f2, F., Gelzo, M., Iacotucci, P., Amato, F., Zarrilli, F., Celardo, A., Castaldo, G., and Corso, G. (2022). Cystic fibrosis patients with F508del\/minimal function genotype: Laboratory and nutritional evaluations after one year of elexacaftor\/tezacaftor\/ivacaftor treatment. J. Clin. Med., 11.","DOI":"10.3390\/jcm11236900"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1016\/j.jcf.2025.03.1215","article-title":"P330 Hypervitaminosis A in children with cystic fibrosis caused by a combination of all-in-one fat-soluble vitamin supplements and elexacaftor\/tezacaftor\/ivacaftor","volume":"24","author":"Joscelyne","year":"2025","journal-title":"J. Cyst. Fibros."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/S1569-1993(24)00656-8","article-title":"P360 CFTR modulator therapy with elexacaftor\/tezacaftor\/ivacaftor increases plasma concentration of fat-soluble carotenoids in patients with cystic fibrosis","volume":"23","author":"Chung","year":"2024","journal-title":"J. Cyst. Fibros."},{"key":"ref_115","unstructured":"Ioannidou, V.K. (2025). Effects of Elexacaftor\/Tezaacaftor\/Ivacaftor Therapy on Lipid and Fat-Soluble Vitamin Profile in Individuals with Cystic Fibrosis: A Systematic Review and Meta-Analysis. [Master\u2019s Thesis, Aristotle University of Thessaloniki]."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"112984","DOI":"10.1016\/j.nut.2025.112984","article-title":"Nutritional outcomes in people with cystic fibrosis receiving elexacaftor\/tezacaftor\/ivacaftor: A 24-month real-world study","volume":"142","author":"Alicandro","year":"2025","journal-title":"Nutrition"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Blaner, W.S., Li, Y., Brun, P.-J., Yuen, J.J., Lee, S.-A., and Clugston, R.D. (2016). Vitamin A absorption, storage and mobilization. The Biochemistry of Retinoid Signaling II: The Physiology of Vitamin A-Uptake, Transport, Metabolism and Signaling, Springer Nature.","DOI":"10.1007\/978-94-024-0945-1_4"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1053\/j.jrn.2022.09.008","article-title":"Vitamin Needs and Treatment for Chronic Kidney Disease Patients","volume":"33","author":"Chazot","year":"2023","journal-title":"J. Ren. Nutr."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00467-014-2916-2","article-title":"Hypervitaminosis A is prevalent in children with CKD and contributes to hypercalcemia","volume":"30","author":"Manickavasagar","year":"2015","journal-title":"Pediatr. Nephrol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jcf.2007.10.001","article-title":"Guidelines for the management of pregnancy in women with cystic fibrosis","volume":"7","author":"Edenborough","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jcf.2021.07.019","article-title":"Pregnancy in cystic fibrosis: Review of the literature and expert recommendations","volume":"21","author":"Jain","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0890-6238(97)00102-0","article-title":"Periconceptional vitamin A use: How much is teratogenic?","volume":"12","author":"Miller","year":"1998","journal-title":"Reprod. Toxicol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Maia, S., Souza, A., Caminha, M., Silva, S., Batista Filho, M., and Lira, P. (2019). Vitamin A and pregnancy: A narrative review. Nutrients, 11.","DOI":"10.3390\/nu11030681"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM199511233332101","article-title":"Teratogenicity of high vitamin A intake","volume":"333","author":"Rothman","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1325S","DOI":"10.1093\/ajcn\/71.5.1325s","article-title":"Vitamin A in pregnancy: Requirements and safety limits","volume":"71","author":"Pascal","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/10408447909043651","article-title":"Hypervitaminosis A induced teratogenesis","volume":"6","author":"Geelen","year":"1979","journal-title":"CRC Crit. Rev. Toxicol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/01.TP.0000151660.69796.10","article-title":"Increased vitamin A and E levels in adult cystic fibrosis patients after lung transplantation","volume":"79","author":"Stephenson","year":"2005","journal-title":"Transplantation"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/TP.0b013e31822790e3","article-title":"Increased serum vitamin A and E levels after lung transplantation","volume":"92","author":"Ho","year":"2011","journal-title":"Transplantation"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0022-3476(99)70059-4","article-title":"Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen","volume":"135","author":"Feranchak","year":"1999","journal-title":"J. Pediatr."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/0884533614530170","article-title":"Relationship between fat-soluble vitamin supplementation and blood concentrations in adolescent and adult patients with cystic fibrosis","volume":"29","author":"Siwamogsatham","year":"2014","journal-title":"Nutr. Clin. Pract."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF02002713","article-title":"Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation","volume":"155","author":"Lancellotti","year":"1996","journal-title":"Eur. J. Pediatr."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/ajcn\/50.5.1064","article-title":"Fat-soluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns","volume":"50","author":"Sokol","year":"1989","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/ppul.25825","article-title":"Vitamins A, D, E status as related to supplementation and lung disease markers in young children with cystic fibrosis","volume":"57","author":"Lai","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1440-1754.2005.00755.x","article-title":"Vitamin A and E deficiency and lung disease in infants with cystic fibrosis","volume":"41","author":"Bines","year":"2005","journal-title":"J. Paediatr. Child Health"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ped4.12270","article-title":"Association of vitamin A status with lung function in children and adolescents with cystic fibrosis","volume":"5","author":"Loukou","year":"2021","journal-title":"Pediatr. Investig."},{"key":"ref_136","first-page":"318","article-title":"Vitamin A deficiency in children with cystic fibrosis","volume":"87","author":"Leyva","year":"2015","journal-title":"Rev. Cuba. Pediatr\u00eda"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0887-8994(93)90033-9","article-title":"Benign intracranial hypertension in an older child with cystic fibrosis","volume":"9","author":"Lucidi","year":"1993","journal-title":"Pediatr. Neurol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/ajcn\/84.1.174","article-title":"Elevated vitamin A intake and serum retinol in preadolescent children with cystic fibrosis","volume":"84","author":"Schall","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jcf.2007.07.002","article-title":"Vitamin A intake and elevated serum retinol levels in children and young adults with cystic fibrosis","volume":"7","author":"Maqbool","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1067\/mpd.2000.111162","article-title":"The vitamin A paradox","volume":"137","author":"Griffiths","year":"2000","journal-title":"J. Pediatr."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ajcn\/83.2.191","article-title":"The acute and chronic toxic effects of vitamin A","volume":"83","author":"Penniston","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Sommerburg, O., H\u00e4mmerling, S., Schneider, S.P., Okun, J., Langhans, C.-D., Leutz-Schmidt, P., Wielp\u00fctz, M.O., Siems, W., Gr\u00e4ber, S.Y., and Mall, M.A. (2021). CFTR modulator therapy with lumacaftor\/ivacaftor alters plasma concentrations of lipid-soluble vitamins A and E in patients with cystic fibrosis. Antioxidants, 10.","DOI":"10.3390\/antiox10030483"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Mouzaki, M., Dupuis, A., Avolio, J., Griffin, K., Ratjen, F., Tullis, E., and Gonska, T. (2023). Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1157459"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jcf.2005.11.007","article-title":"Vitamin A and lung function in CF","volume":"5","author":"Aird","year":"2006","journal-title":"J. Cyst. Fibros."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/MPG.0b013e31828b1d90","article-title":"High serum retinol and lung function in young patients with cystic fibrosis","volume":"56","author":"Aguirre","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/jpr3.70007","article-title":"Effect of cystic fibrosis modulator therapies on serum levels of fat-soluble vitamins","volume":"6","year":"2025","journal-title":"JPGN Rep."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/j.jcf.2022.01.010","article-title":"Hypervitaminosis A with fulminant secondary intracranial hypertension following personalized medicine-based Elexacaftor\/Tezacaftor\/Ivacaftor initiation in a preadolescent with cystic fibrosis","volume":"21","author":"Wisniewski","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Legere, B., Orozco, P., Genovese, S., Cohen, R., Fernandez, T., Patton, C., Nguyen, M.C., and Nevel, R.J. (2026). Navigating New Tensions: An Early Childhood Case of Intracranial Hypertension With CFTR Modulator Therapy. Clin. Ther., in press.","DOI":"10.1016\/j.clinthera.2026.04.011"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.clinthera.2025.07.007","article-title":"Raised Intracranial Pressure in Children Treated With Elexacaftor\/Tezacaftor\/Ivacaftor: Need for Surveillance","volume":"47","author":"Fevola","year":"2025","journal-title":"Clin. Ther."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e27455","DOI":"10.1002\/ppul.27455","article-title":"Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor\/Tezacaftor\/Ivacaftor: A Multicenter Case Series","volume":"60","author":"Kam","year":"2025","journal-title":"Pediatr. Pulmonol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/ppul.27152","article-title":"Idiopathic intracranial hypertension in a pediatric patient with cystic fibrosis on ETI generic formulation treatment","volume":"59","author":"Vidaurreta","year":"2024","journal-title":"Pediatr. Pulmonol."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Olivier, M., Kavvalou, A., Welsner, M., Hirtz, R., Stra\u00dfburg, S., Sutharsan, S., Stehling, F., and Steindor, M. (2023). Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosis. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1176815"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/jhn.13214","article-title":"Nutritional management of people living with cystic fibrosis throughout life and disease continuum: Changing times, new challenges","volume":"36","author":"Mailhot","year":"2023","journal-title":"J. Hum. Nutr. Diet."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"e71596","DOI":"10.1002\/ppul.71596","article-title":"The Impact of Elexacaftor\/Tezacaftor\/Ivacaftor on Fat-Soluble Vitamin Status and Supplementation in a Pediatric Cystic Fibrosis Cohort","volume":"61","author":"Kimber","year":"2026","journal-title":"Pediatr. Pulmonol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1164\/rccm.201906-1227OC","article-title":"Real-life safety and effectiveness of lumacaftor\u2013ivacaftor in patients with cystic fibrosis","volume":"201","author":"Burgel","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_156","unstructured":"(2026, June 24). MVW. Available online: https:\/\/mvwnutritionals-assets.s3.amazonaws.com\/wp-content\/uploads\/2025\/11\/19134444\/Vitamin-Comparison-Chart-4_11_2024-FINAL-2.pdf."},{"key":"ref_157","unstructured":"(2026, June 24). MVW. Available online: https:\/\/mvwnutritionals.com."},{"key":"ref_158","unstructured":"(2026, June 24). Dekasvitamins.com. Available online: https:\/\/dekasvitamins.com\/?srsltid=AfmBOoqzTCGHcc5bEds67xUCp_YpGXvULwMaI4-PKuxt7diLccF0Iiiq."},{"key":"ref_159","unstructured":"(2026, June 01). Available online: https:\/\/dekasvitamins.com."},{"key":"ref_160","unstructured":"(2026, June 24). Dekasvitamins.com. Available online: https:\/\/dekasvitamins.com\/wp-content\/uploads\/2025\/03\/DEKAs_brochure_CF_V6_Nov2023_turnpage_light.pdf."},{"key":"ref_161","first-page":"47","article-title":"Pregnancy in people with cystic fibrosis treated with highly effective modulator therapy","volume":"145","author":"Goralski","year":"2025","journal-title":"Obstet. Gynecol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jand.2012.08.010","article-title":"Nutrition for pregnant women who have cystic fibrosis","volume":"112","author":"Michel","year":"2012","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcf.2017.11.009","article-title":"Drugs during pregnancy and breast feeding in women diagnosed with Cystic Fibrosis-An update","volume":"17","author":"Kroon","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e004270","DOI":"10.1136\/bmjresp-2026-004270","article-title":"Maternal, Infant, Reproductive and Child Health in Cystic Fibrosis (MATRIARCH_CF): A prospective, observational study to evaluate pregnancy and parenthood in females with cystic fibrosis and health of the offspring in the CFTR-modulator era","volume":"13","author":"Downes","year":"2026","journal-title":"BMJ Open Respir. Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2213-2600(26)00120-7","article-title":"Reproductive health guidance for the cystic fibrosis community: A Cystic Fibrosis Foundation Position Paper","volume":"14","author":"Jain","year":"2026","journal-title":"Lancet Respir. Med."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.jpeds.2009.09.003","article-title":"Cystic fibrosis foundation practice guidelines for the management of infants with CFTR-related metabolic syndrome during the first two years of life and beyond","volume":"155","author":"Borowitz","year":"2009","journal-title":"J. Pediatr."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ajcn\/55.1.108","article-title":"Nutritional assessment and management in cystic fibrosis: A consensus report","volume":"55","author":"Ramsey","year":"1992","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1478-3231.2005.01207.x","article-title":"Hypervitaminosis A-induced liver fibrosis: Stellate cell activation and daily dose consumption","volume":"26","author":"Nollevaux","year":"2006","journal-title":"Liver Int."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/0016-5085(91)90672-8","article-title":"Liver damage caused by therapeutic vitamin A administration: Estimate of dose-related toxicity in 41 cases","volume":"100","author":"Geubel","year":"1991","journal-title":"Gastroenterology"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"621342","DOI":"10.1155\/2014\/621342","article-title":"Practical guidelines: Lung transplantation in patients with cystic fibrosis","volume":"2014","author":"Hirche","year":"2014","journal-title":"Pulm. Med."},{"key":"ref_171","first-page":"74","article-title":"Night Blindness Secondary to Vitamin A Deficiency in a Patient with Cystic Fibrosis and Short-Gut Syndrome","volume":"59","author":"Leung","year":"2006","journal-title":"Can. J. Hosp. Pharm."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1016\/S1569-1993(24)00666-0","article-title":"P370 Night blindness in a cystic fibrosis (CF) patient; can we correct suboptimal vitamin A orally?","volume":"23","author":"Still","year":"2024","journal-title":"J. Cyst. Fibros."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/MCG.0000000000000911","article-title":"Fat-soluble vitamin deficiencies and inflammatory bowel disease: Systematic review and meta-analysis","volume":"51","author":"Fabisiak","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MPG.0b013e31826a105d","article-title":"Vitamin and mineral status in patients with inflammatory bowel disease","volume":"56","author":"Alkhouri","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Scarampi, M., Mengoli, C., Miceli, E., and Di Stefano, M. (2025). Vitamins and celiac disease: Beyond Vitamin D. Metabolites, 15.","DOI":"10.3390\/metabo15020078"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"28315","DOI":"10.1038\/s41598-025-12631-1","article-title":"Vitamin and trace elements imbalance are very common in adult patients with newly diagnosed Celiac disease","volume":"15","author":"Nuermaimaiti","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Imrei, M., Nemeth, D., Szakacs, Z., Hegyi, P., Kiss, S., Alizadeh, H., Dembrovszky, F., Pazmany, P., Bajor, J., and Parniczky, A. (2021). Increased prevalence of celiac disease in patients with cystic fibrosis: A systematic review and meta-analysis. J. Pers. Med., 11.","DOI":"10.3390\/jpm11090859"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"e0016725","DOI":"10.1128\/jb.00167-25","article-title":"Cystic fibrosis and inflammatory bowel disease: Parallels in gut physiology and microbiota","volume":"207","author":"Barrack","year":"2025","journal-title":"J. Bacteriol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S1569-1993(24)00601-5","article-title":"P303 Prevalence and clinical presentation of inflammatory bowel disease (IBD) in a large adult cystic fibrosis (CF) Unit","volume":"23","author":"Abel","year":"2024","journal-title":"J. Cyst. Fibros."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcf.2019.05.007","article-title":"Highlights from the nutrition guidelines for cystic fibrosis in Australia and New Zealand","volume":"19","author":"King","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_181","unstructured":"WHO (2026, June 23). Vitamin A Supplementation. Available online: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/essential-programme-on-immunization\/integration\/linking-with-other-health-interventions\/vitamin-a."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/16\/2639\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:48:14Z","timestamp":1786546094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/16\/2639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":181,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["nu18162639"],"URL":"https:\/\/doi.org\/10.3390\/nu18162639","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}